China has introduced a series of measures to stabilize its stock markets amid economic uncertainty and rising tensions with ...

BEIJING -- China's financial regulatory authority has approved the launch of the second batch of pilot programs for long-term ...

Analysts see China’s latest initiatives injecting at least 1 trillion yuan ($138 billion) of additional flows in 2025 into ...

China will direct medium- and ... The proportion of the funds’ investments in the stock market would be gradually increased and a long-term system will be set up to track these investments ...

China announced new measures to promote the development of index investment products, its latest effort to shore up the ...

Accuray Incorporated ARAY recently announced that its Radixact SynC System and CyberKnife S7 System have been approved by the Chinese National Medical Products Administration. These approvals are ...

China said on Wednesday it will guide big state insurers and commercial insurance funds to increase investments in the ...

FTG has received approval from the Civil Aviation Administration of China to operate as an Approved ... potentially strengthening its market position and offering new opportunities for growth.

China on Thursday detailed measures to encourage state-owned funds and insurers to buy more shares, aimed at stabilizing the ...

This positions L&C Bio not only for market entry but also for establishing a decisive foothold in China's regenerative ... with the NMPA approval. CEO Hwan-Chul Lee stated, "Stock prices reflect ...

This approval marks the third indication for mepolizumab in China and offers patients a non-surgical treatment alternative to systemic corticosteroids and surgery. The approval is based on ...